文献速递膀胱癌与上尿路尿路上皮癌

根治性膀胱切除术后手术切缘阳性对肿瘤学结局的影响:一项全国性研究

The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study.
PubMed 文献 · BJU Int · 2024-12-04

这项全国性队列研究纳入2017年11月至2020年12月荷兰癌症登记中1445例接受根治性膀胱切除的肌层浸润性膀胱癌患者,135例(9.3%)切缘阳性。多变量Cox回归显示切缘含浸润癌患者无进展生存(HR 2.13,95%CI 1.67-2.72)和总生存(HR 2.02,95%CI 1.58-2.58)较切缘阴性者更差。作者认为切缘阳性应视为高危特征,并支持进一步研究辅助治疗在切缘阳性患者中的潜在疗效。

要点

  • 1445例肌层浸润性膀胱癌根治性膀胱切除患者中135例(9.3%)手术切缘阳性。
  • 切缘含浸润癌者无进展生存HR 2.13(95%CI 1.67-2.72),总生存HR 2.02(95%CI 1.58-2.58)。
  • 切缘仅含原位癌者无进展生存HR 1.60(95%CI 1.00-2.58),未达统计学显著。

核心结论

  • 手术切缘阳性应被视为高危特征,因其导致疾病进展风险增加和生存结局受损。
  • 作者认为这些发现支持进一步研究辅助治疗(即放疗和全身治疗)在手术切缘阳性患者中的潜在疗效。

研究设计与样本

  • 全国性队列研究,从荷兰癌症登记处选取2017年11月至2020年12月诊断为肌层浸润性膀胱癌且无淋巴结或远处转移(cT2-4aN0/xM0)、接受根治性膀胱切除、年龄≥18岁的患者。
  • 通过链接荷兰中央病理数据库Palga获取手术切缘状态的详细信息。
  • 采用Kaplan-Meier法评估总生存和无进展生存,多变量Cox回归分析评估手术切缘阳性(仅原位癌或浸润癌)对无进展生存和总生存的独立预后效应。

主要发现

  • 共识别1445例接受根治性膀胱切除的肌层浸润性膀胱癌患者(53%开放手术,47%机器人辅助),其中135例(9.3%)手术切缘阳性(开放手术组10.7%,机器人辅助组7.7%)。
  • 整个队列根治性膀胱切除术后12个月和48个月总生存分别为79%和60%。
  • 无进展生存在12个月和24个月分别为70%和61%。
  • 多变量Cox回归显示,与切缘阴性患者相比,切缘含浸润癌患者无进展生存更差(HR 2.13,95%CI 1.67-2.72),总生存更差(HR 2.02,95%CI 1.58-2.58)。
  • 切缘仅含原位癌患者无进展生存似乎也更差(HR 1.60,95%CI 1.00-2.58),但结果未达统计学显著;总生存未见差异(HR 1.30,95%CI 0.80-2.12)。

临床怎么用

  • 作者认为手术切缘阳性应被视为高危特征。
  • 作者认为这些发现支持进一步研究辅助治疗(即放疗和全身治疗)在手术切缘阳性患者中的潜在疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether surgical margin status, alongside existing postoperative risk indicators, improves the identification of bladder cancer patients who may benefit from adjuvant therapy following radical cystectomy (RC). METHODS: In this nationwide cohort study, patients aged ≥18 years diagnosed with muscle-invasive bladder cancer (MIBC) without nodal or distant metastasis (cT2-4aN0/xM0) between November 2017 and December 2020 who underwent RC were selected from the Netherlands Cancer Registry. Detailed information on surgical margin status was obtained through linkage with the Dutch central pathology database, Palga. Overall survival (OS) and progression-free survival (PFS) were assessed using the Kaplan-Meier method. Multivariable Cox regression analysis was performed to assess the independent prognostic effect of positive surgical margins (carcinoma in situ (CIS) only or invasive carcinoma) on PFS and OS. RESULTS: We identified 1445 MIBC patients treated by RC (53% open, 47% robot-assisted), of whom 135 (9.3%) had positive surgical margins (10.7% in the open and 7.7% in the robot-assisted cohort). In the entire cohort, OS was 79% and 60% at 12 and 48 months after RC, respectively. PFS was 70% and 61% at 12 and 24 months, respectively. Multivariable Cox regression showed worse PFS (hazard ratio (HR) 2.13, 95% confidence interval (CI) 1.67-2.72) and OS (HR 2.02, 95% CI 1.58-2.58) in patients with surgical margins with invasive carcinoma vs patients with negative margins. Patients with only CIS in the margins also appeared to have worse PFS (HR 1.60, 95% CI 1.00-2.58) but these results were not statistically significant. No difference was found for OS (HR 1.30, 95% CI 0.80-2.12). CONCLUSION: Positive margins should be considered a 'high risk feature', as they result in increased risk of disease progression and impaired survival outcomes. These findings support further investigation of the potential efficacy of adjuvant therapy (i.e., radiotherapy and systemic therapy) among patients with positive surgical margins.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Bosveld J, Nguyen TQ, Boormans JL, et al. The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study. BJU Int. 2024. PMID: 39631746. doi:10.1111/bju.16611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。